Cypress Capital Management LLC Zoetis Inc. Transaction History

Cypress Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$148.29 - $182.55 $61,095 - $75,210	-412 Reduced 14.0%	2,530 $375,000
Q2 2022 Aug 10, 2022	BUY	$155.97 - $200.09 $145,831 - $187,084	935 Added 46.59%	2,942 $506,000
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $14,511 - $18,722	80 Added 4.15%	2,007 $379,000
Q4 2021 Feb 22, 2022	SELL	$193.69 - $247.03 $3,486 - $4,446	-18 Reduced 0.93%	1,927 $470,000
Q1 2021 May 12, 2021	BUY	$144.0 - $169.39 $34,560 - $40,653	240 Added 14.08%	1,945 $306,000
Q4 2020 Feb 08, 2021	SELL	$157.07 - $174.35 $90,315 - $100,251	-575 Reduced 25.22%	1,705 $282,000
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $21,250 - $25,632	155 Added 7.29%	2,280 $377,000
Q3 2019 Nov 01, 2019	BUY	$112.57 - $128.43 $239,211 - $272,913	2,125 New	2,125 $265,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC with notifications on news.